Voluntary scheme quarterly net sales and payment information
Information on how the voluntary scheme for branded medicines pricing and access is controlling spend on branded medicines in the NHS.
This collection will no longer be updated.
This page holds quarterly aggregate net sales from:
- 2019 voluntary scheme for branded medicines pricing and access members
- companies regulated by the Branded Health Service Medicines (Costs) Regulations 2018.
It also holds information received on parallel imports.
The voluntary scheme started on 1 January 2019, replacing the pharmaceutical price regulation scheme 2014 (PPRS).
2024
2023
2022
2021
2020
2019
Updates to this page
Published 23 October 2019Last updated 8 March 2024 + show all updates
-
Added 'Voluntary scheme aggregate net sales and payment information: February 2024'.
-
Added 'Voluntary scheme aggregate net sales and payment information: November 2023'.
-
Added 'Voluntary scheme aggregate net sales and payment information: August 2023'.
-
Added Voluntary scheme aggregate net sales and payment information: May 2023 to collection.
-
Added Voluntary scheme aggregate net sales and payment information: February 2023.
-
Added 'Voluntary scheme aggregate net sales and payment information: November 2022'.
-
Added 'Voluntary scheme aggregate net sales and payment information: August 2022'.
-
Added 'Voluntary scheme aggregate net sales and payment information: May 2022'.
-
Added voluntary scheme aggregate net sales and payment information: February 2022.
-
Added voluntary scheme aggregate net sales and payment information: November 2021.
-
Added 'Voluntary scheme aggregate net sales and payment information: August 2021'
-
Added 'Voluntary scheme aggregate net sales and payment information: May 2021'.
-
First published.